In an interview from ADA 2022, Alaina Vidmar, MD, discusses a study she led examining trends in diagnosis of type 2 diabetes among youth in the US using a database with information on 86 million patients.
Data from the AWARD-PEDS study presented at ADA 2022 suggest once-weekly dulaglutide could improve glycemic control in youth with type 2 diabetes, with a safety profile consistent with that observed in adult patients.
Data from a 1-year pragmatic trial examining use of a mobile health support system outlines the potential impact of using the system on weight loss and treatment effects among patients with pediatric obesity.
An analysis of more than 100 mother-child pairs from Colorado found children with fetal exposure to cannabis had increased fat mass and fasting glucose levels compared to their counterparts without fetal exposure to cannabis.
Results of a noninferiority trial comparing closed-loop delivery versus delivery via an open-loop system suggest use of a closed-loop system was noninferior for pediatric patients aged 6-12 years with type 1 diabetes.
Data from a retrospective cohort analysis suggests a single 60-minute post gonadotropin-releasing hormone agonist stimulation test could provide a more convenient avenue for diagnosing idiopathic central precocious puberty in girls.
Data from a New York-based cohort of mother-child dyads details the impact of gestational weight gain patterns on childhood growth trajectories and how trajectories differ among male and female children.
An analysis of data from 1860 mother-child pairs suggests presence of abnormal maternal thyroid hormone levels could help in the prediction of behavioral and emotional health problems in male offspring at 4 years of age.